These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8834178

  • 1. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
    Amler LC, Schürmann J, Schwab M.
    Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178
    [Abstract] [Full Text] [Related]

  • 2. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
    Squire JA, Thorner PS, Weitzman S, Maggi JD, Dirks P, Doyle J, Hale M, Godbout R.
    Oncogene; 1995 Apr 06; 10(7):1417-22. PubMed ID: 7731693
    [Abstract] [Full Text] [Related]

  • 3. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus.
    Noguchi T, Akiyama K, Yokoyama M, Kanda N, Matsunaga T, Nishi Y.
    Genes Chromosomes Cancer; 1996 Feb 06; 15(2):129-33. PubMed ID: 8834177
    [Abstract] [Full Text] [Related]

  • 4. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN.
    Kuroda H, White PS, Sulman EP, Manohar CF, Reiter JL, Cohn SL, Brodeur GM.
    Oncogene; 1996 Oct 03; 13(7):1561-5. PubMed ID: 8875996
    [Abstract] [Full Text] [Related]

  • 5. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
    Karlsson A, Helou K, Walentinsson A, Hedrich HJ, Szpirer C, Levan G.
    Genes Chromosomes Cancer; 2001 Aug 03; 31(4):345-56. PubMed ID: 11433525
    [Abstract] [Full Text] [Related]

  • 6. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.
    Weber A, Imisch P, Bergmann E, Christiansen H.
    J Clin Oncol; 2004 Jul 01; 22(13):2681-90. PubMed ID: 15226335
    [Abstract] [Full Text] [Related]

  • 7. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
    George RE, Kenyon RM, McGuckin AG, Malcolm AJ, Pearson AD, Lunec J.
    Oncogene; 1996 Apr 04; 12(7):1583-7. PubMed ID: 8622876
    [Abstract] [Full Text] [Related]

  • 8. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma.
    Wimmer K, Zhu XX, Lamb BJ, Kuick R, Ambros P, Kovar H, Thoraval D, Elkahloun A, Meltzer P, Hanash SM.
    Med Pediatr Oncol; 2001 Jan 04; 36(1):75-9. PubMed ID: 11464910
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines.
    Akiyama K, Akao Y, Yokoyama M, Nakagawa Y, Noguchi T, Yagi K, Nishi Y.
    Biochem Mol Biol Int; 1999 Apr 04; 47(4):563-8. PubMed ID: 10319407
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines.
    Godbout R, Packer M, Bie W.
    J Biol Chem; 1998 Aug 14; 273(33):21161-8. PubMed ID: 9694872
    [Abstract] [Full Text] [Related]

  • 14. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH.
    Pandita A, Godbout R, Zielenska M, Thorner P, Bayani J, Squire JA.
    Genes Chromosomes Cancer; 1997 Nov 14; 20(3):243-52. PubMed ID: 9365831
    [Abstract] [Full Text] [Related]

  • 15. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA, Lazarova DL, Ross RA, Biedler JL.
    Oncol Res; 1997 Nov 14; 9(9):467-76. PubMed ID: 9495452
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis.
    Spieker N, Beitsma M, van Sluis P, Roobeek I, den Dunnen JT, Speleman F, Caron H, Versteeg R.
    Genes Chromosomes Cancer; 2000 Feb 14; 27(2):143-52. PubMed ID: 10612802
    [Abstract] [Full Text] [Related]

  • 18. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G, Cesi V, Amendola R, Negroni A, Tanno B, Altavista P, Tonini GP, De Bernardi B, Calabretta B.
    Cancer Res; 1999 Jul 15; 59(14):3365-8. PubMed ID: 10416595
    [Abstract] [Full Text] [Related]

  • 19. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.
    Corvi R, Savelyeva L, Schwab M.
    Cancer Res; 1995 Aug 15; 55(16):3471-4. PubMed ID: 7627947
    [Abstract] [Full Text] [Related]

  • 20. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
    O'Neill S, Ekstrom L, Lastowska M, Roberts P, Brodeur GM, Kees UR, Schwab M, Bown N.
    Genes Chromosomes Cancer; 2001 Jan 15; 30(1):87-90. PubMed ID: 11107180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.